Mandate

Vinge advises Adelis in connection with the acquisition of Logent

November 12, 2013

Vinge is advising Adelis Equity Partners Fund 1 AB in connection with its acquisition of Logent AB (“Logent”) from the company’s two founders and Inter IKEA Investments AB. The acquisition is taking place together with the company’s management. It is anticipated that the transaction will be completed by the end of November 2013. Logent was founded in 2006 and has had growth in sales over the last five years of more than 60% per year, both organically and as a result of strategic acquisitions. Logent currently has an extensive network of on-site solutions in Sweden and Norway and has approximately 3500 employees. Logent’s turnover for 2013 is expected to amount to approximately SEK 1.3 billion.

Vinge’s team consists of responsible partner Christina Kokko together with Johan Mattsson and Gustav Jönsson. Partner Mikael Ståhl and associates Sofia Graflund and Emelie Klefbeck advised on acquisition financing issues. Partners Mattias Scömer, Odile Fallenius and Johan Larsson and associates Ulf Nilsson and Emelie Parland advised Adelis in relation to funds, tax, and VAT issues.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026